H. Wieand

发表

Revision of the American Joint Committee on Cancer staging system for breast cancer.

Donald L Weaver, Kirby I Bland, Gary Clark, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic.

T. Fleming, H. Wieand, J. Laurie, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

p53 gene expression in node-positive breast cancer: relationship to DNA ploidy and prognosis.

S. Cha, J. Cunningham, J. Ingle, 1994, Journal of the National Cancer Institute.

Prognostic value of thymidylate synthase, Ki-67, and p53 in patients with Dukes' B and C colon cancer: a National Cancer Institute-National Surgical Adjuvant Breast and Bowel Project collaborative study.

Norman Wolmark, Patrick G Johnston, P. Johnston, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Flow-cytometric analysis of deoxyribonucleic acid content in advanced ovarian carcinoma: its importance in long-term survival.

S. Cha, G. Farr, J. Katzmann, 1996, American journal of obstetrics and gynecology.

Oral uracil and tegafur plus leucovorin compared with intravenous fluorouracil and leucovorin in stage II and III carcinoma of the colon: results from National Surgical Adjuvant Breast and Bowel Project Protocol C-06.

N. Petrelli, N. Wolmark, M. O’connell, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Perioperative blood transfusions do not affect disease recurrence of patients undergoing curative resection of colorectal carcinoma: a Mayo/North Central Cancer Treatment Group study.

R. Fitzgibbons, S. Cha, J. Donohue, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase 2 bioadjuvant study of interferon alfa-2a, isotretinoin, and vitamin E in locally advanced squamous cell carcinoma of the head and neck: long-term follow-up.

Edward S. Kim, F. Khuri, W. Hong, 2005, Archives of otolaryngology--head & neck surgery.

Controlled clinical trial of interferon-gamma as postoperative surgical adjuvant therapy for colon cancer.

R. Fitzgibbons, J. Donohue, J. Krook, 1995, Journal of Clinical Oncology.

Neurotoxicity from oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: NSABP C-07.

J. Kopec, D. Cella, J. Costantino, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized trial of adjuvant therapy in colon carcinoma: 10-year results of NSABP protocol C-01.

N. Wolmark, Roy E. Smith, M. Begovic, 2004, Journal of the National Cancer Institute.

Granulocyte colony-stimulating factor in severe chemotherapy-induced afebrile neutropenia.

T. Habermann, L. Hartmann, H. Wieand, 1997, The New England journal of medicine.

Randomized trial of observation versus adjuvant therapy with cyclophosphamide, fluorouracil, prednisone with or without tamoxifen following mastectomy in postmenopausal women with node-positive breast cancer.

J. K. Martin, J. Ingle, J. Krook, 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Adjuvant therapy for resectable colorectal carcinoma with fluorouracil administered by portal vein infusion. A study of the Mayo Clinic and the North Central Cancer Treatment Group.

R. Fitzgibbons, R. Beart, H. Wieand, 1990, Archives of surgery.

Biochemical modulation of fluorouracil with leucovorin: confirmatory evidence of improved therapeutic efficacy in advanced colorectal cancer.

H. Wieand, J. Krook, M. O’connell, 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pemetrexed/oxaliplatin for first-line treatment of patients with advanced colorectal cancer: a phase II trial of the National Surgical Adjuvant Breast and Bowel Project Foundation Research Program.

C. Geyer, N. Wolmark, Roy E. Smith, 2005, Clinical colorectal cancer.

Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07.

N. Petrelli, N. Wolmark, M. O’connell, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Controlled evaluation of three drug combination regimens versus fluorouracil alone for the therapy of advanced gastric cancer. North Central Cancer Treatment Group.

H. Wieand, J. Krook, M. O’connell, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Disease‐free survival at intervals during and following completion of adjuvant chemotherapy: The NSABP experience from three breast cancer protocols

C. Redmond, N. Wolmark, B. Fisher, 1981, Cancer.

Recurrent disease after negative second-look laparotomy in stages III and IV ovarian carcinoma

Raymond A. Lee, S. Cha, G. Malkasian, 1988 .

Accuracy of fecal occult blood screening for colorectal neoplasia: A prospective study using Hemoccult and Hemo‐Quant tests

D. Ahlquist, M. O’connell, H. Wieand, 1993 .

Proliferating cell nuclear antigen in epithelial ovarian cancer: relation to results at second-look laparotomy and survival.

S. Cha, L. Hartmann, T. Sebo, 1992, Gynecologic oncology.

Colorectal cancer. Dukes' stage, tumor site, preoperative plasma CEA level, and patient prognosis related to tumor DNA ploidy pattern.

S. Cha, H. Wieand, R. Beart, 1987, Archives of surgery.

Intra-arterial floxuridine vs systemic fluorouracil for hepatic metastases from colorectal cancer. A randomized trial.

J. K. Martin, R. Fitzgibbons, H. Wieand, 1990, Archives of surgery.

Future directions in the adjuvant treatment of colon cancer.

D. Wickerham, N. Wolmark, E. Mamounas, 1997, Oncology.

The Prognostic Significance of Preoperative Carcinoembryonic Antigen Levels in Colorectal Cancer: Results from NSABP Clinical Trials

N. Wolmark, B. Fisher, N. Dimitrov, 1984 .

The prognostic significance of tumor location and bowel obstruction in Dukes B and C colorectal cancer. Findings from the NSABP clinical trials.

H. Rockette, H. Wieand, N. Wolmark, 1983, Annals of surgery.

The relationship of depth of penetration and tumor size to the number of positive nodes in dukes C colorectal cancer

B. Fisher, E. Fisher, H. Wieand, 1984, Cancer.

Expression of anionic glutathione-S-transferase and P-glycoprotein genes in human tissues and tumors.

H. Wieand, K. Cowan, C. Fairchild, 1989, Cancer research.

The methodologic dilemma in retrospectively correlating the amount of chemotherapy received in adjuvant therapy protocols with disease-free survival.

C. Redmond, B. Fisher, H. Wieand, 1983, Cancer treatment reports.

Phase II Studies of Bleomycin, Cyclophosphamide, Doxorubicin and Cisplatin, and Bleomycin and Cisplatin in Advanced Cervical Carcinoma

J. Edmonson, G. Malkasian, J. A. Jefferies, 1988, American journal of clinical oncology.

Evaluation of external-beam radiation therapy plus 5-fluorouracil (5-FU) versus external-beam radiation therapy plus hycanthone (HYC) in confined, unresectable pancreatic cancer.

J. Earle, L. Kvols, J. Krook, 1994, International journal of radiation oncology, biology, physics.

Cyclophosphamide-cisplatin versus cyclophosphamide-carboplatin in stage III-IV ovarian carcinoma: a comparison of equally myelosuppressive regimens.

J. Edmonson, G. Malkasian, J. Laurie, 1989, Journal of the National Cancer Institute.

Evaluation of treatment and survival after positive second-look laparotomy.

H. Wieand, G. Malkasian, J. A. Jefferies, 1988 .

A phase III trial on the therapy of advanced pancreatic carcinoma evaluations of the mallinson regimen and combined 5‐fluorouracil, doxorubicin, and cisplatin

J. Krook, B. Norris, H. Wieand, 1990, Cancer.

A phase II study of combined 5-fluorouracil, doxorubicin, and cisplatin in the treatment of advanced upper gastrointestinal adenocarcinomas.

M. O’connell, J. Rubin, H. Wieand, 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II trial of methotrexate, vinblastine, doxorubicin, and cisplatin in advanced/recurrent carcinoma of the uterine cervix and vagina.

M. J. Webb, J. Kugler, H. Wieand, 1995, Gynecologic oncology.

Stage I ovarian epithelial carcinoma: survival analysis following definitive treatment.

S. Cha, H. Wieand, K. Podratz, 1991, Gynecologic oncology.

Role of hexamethylmelamine in the treatment of ovarian cancer: where is the needle in the haystack?

J. Edmonson, H. Wieand, G. McCormack, 1988, Journal of the National Cancer Institute.

Evaluation of treatment and survival after positive second‐look laparotomy

J. Edmonson, G. Malkasian, J. A. Jefferies, 1989, Gynecologic oncology.

Recurrent disease after negative second-look laparotomy in stages III and IV ovarian carcinoma.

S. Cha, G. Malkasian, K. Podratz, 1988, Gynecologic oncology.

Evaluation of Ifosfamide Plus Mesna as First‐Line Chemotherapy in Women with Metastatic Breast Cancer

J. Ingle, J. Krook, H. Wieand, 1995, American journal of clinical oncology.

A phase ii study of the combination of etoposide and cisplatin in the therapy of advanced gastric cancer

H. Wieand, R. Hahn, H. Wieand, 1990, Cancer.

A clinical trial of biochemical modulation of 5‐fluorouracil with N‐phosphonoacetyl‐L‐aspartate and thymidine in advanced gastric and anaplastic colorectal cancer

R. Goldberg, J. Laurie, J. Krook, 1990, Cancer.

Accuracy of fecal occult blood screening for colorectal neoplasia. A prospective study using Hemoccult and HemoQuant tests.

H. Wieand, D. Ahlquist, C. Loprinzi, 1993, JAMA.

A phase II evaluation of menogaril in cisplatin‐refractory advanced ovarian carcinoma. A collaborative trial of the north central cancer treatment group and the mayo clinic

J. Laurie, J. Krook, J. Edmonson, 1991, Cancer.

Phase II evaluation of carboplatin in advanced endometrial carcinoma.

J. Buckner, J. Edmonson, H. Wieand, 1988, Journal of the National Cancer Institute.

Acute toxicity during adjuvant chemotherapy for breast cancer: the National Surgical Adjuvant Breast and Bowel Project (NSABP) experience from 1717 patients receiving single and multiple agents.

C. Redmond, R. Foster, N. Wolmark, 1981, Cancer treatment reports.

Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma.

J. Laurie, M. O’connell, H. Wieand, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The incidence of lung carcinoma after surgery for breast carcinoma with and without postoperative radiotherapy

N. Wolmark, B. Fisher, M. Begovic, 2003, Cancer.

Comparison of portal and peripheral blood levels of carcinoembryonic antigen, CA 19-9, and CA 125 tumor-associated antigens in patients with colorectal and pancreatic cancer.

D. Nagorney, H. Wieand, R. E. Ritts, 1989, Cancer research.

Flow cytometric DNA analysis of stage I endometrial carcinoma.

K. Podratz, H. Wieand, M. Lieber, 1989, Gynecologic oncology.

Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02.

H. Rockette, N. Petrelli, D. Wickerham, 2000, Journal of the National Cancer Institute.

Effective surgical adjuvant therapy for high-risk rectal carcinoma.

W. Meyers, S. Cha, H. Wieand, 1991, The New England journal of medicine.

Prostate-specific antigen as a pretherapy prognostic factor in patients treated with radiation therapy for clinically localized prostate cancer.

S. Cha, J. Oesterling, J. Earle, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Patterns of occult bleeding in asymptomatic colorectal cancer

D. Ahlquist, H. Wieand, C. Moertel, 1990, Cancer.

Validation studies for models projecting the risk of invasive and total breast cancer incidence.

J Benichou, M H Gail, C K Redmond, 1999, Journal of the National Cancer Institute.

c‐erbB‐2 and p53 expression in fallopian tube carcinoma

L. Hartmann, P. Roche, K. Podratz, 1995, Cancer.

Patterns of recurrence after curative resection of carcinoma of the colon and rectum.

R. Fitzgibbons, S. Cha, S. Galandiuk, 1992, Surgery, gynecology & obstetrics.

Staging system for breast cancer: revisions for the 6th edition of the AJCC Cancer Staging Manual.

S. Edge, S. Singletary, L. Bassett, 2003, The Surgical clinics of North America.

Prognostic and predictive roles of high-degree microsatellite instability in colon cancer: a National Cancer Institute-National Surgical Adjuvant Breast and Bowel Project Collaborative Study.

Norman Wolmark, Soonmyung Paik, S. Paik, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prognosis after rectal cancer in blacks and whites participating in adjuvant therapy randomized trials.

N. Wolmark, Roy E. Smith, E. Mamounas, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Tumor Growth Inhibition by Simultaneously Blocking Epidermal Growth Factor Receptor and Cyclooxygenase-2 in a Xenograft Model

F. Khuri, Z. Chen, D. Shin, 2005, Clinical Cancer Research.

The Prognostic Significance of Tumor Location and Bowel Obstruction in Dukes B and C Colorectal Cancer

H. Rockette, N. Wolmark, A. Glass, 1983 .

Randomized comparison of two schedules of fluorouracil and leucovorin in the treatment of advanced colorectal cancer.

H. Wieand, J. Krook, M. O’connell, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The Prognostic Value of the Modifications of the Dukes' C Class of Colorectal Cancer: An Analysis of the NSABP Clinical Trials

N. Wolmark, B. Fisher, H. Wieand, 1986, Annals of surgery.

Chemotherapy sensitivity and response assays: are the ASCO guidelines for clinical trial design too restrictive?

H. Wieand, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Designs for group sequential phase II clinical trials.

T M Therneau, M N Chang, H S Wieand, 1987, Biometrics.

Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer.

H. Wieand, M. O’connell, D. Haller, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Simultaneously Targeting Epidermal Growth Factor Receptor Tyrosine Kinase and Cyclooxygenase-2, an Efficient Approach to Inhibition of Squamous Cell Carcinoma of the Head and Neck

J. Grandis, Z. Chen, D. Shin, 2004, Clinical Cancer Research.

A quality-adjusted time without symptoms or toxicity (Q-TWiST) analysis of adjuvant radiation therapy and chemotherapy for resectable rectal cancer.

R. Gelber, H. Wieand, A. Goldhirsch, 1996, Journal of the National Cancer Institute.

Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer.

M. Kahn, R. Fitzgibbons, J. Donohue, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

End points for colon cancer adjuvant trials: observations and recommendations based on individual patient data from 20,898 patients enrolled onto 18 randomized trials from the ACCENT Group.

Daniel J Sargent, Greg Yothers, Daniel G Haller, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Revision o f t he A merican J oint C ommittee o n C ancer Staging S ystem f or B reast C ancer

S. Edge, S. Singletary, L. Bassett, 2011 .

A phase III evaluation of a somatostatin analogue (octreotide) in the treatment of patients with asymptomatic advanced colon carcinoma

R. Goldberg, J. Krook, H. Wieand, 1995, Cancer.

The relative prognostic value of flow cytometric DNA analysis and conventional clinicopathologic criteria in patients with operable rectal carcinoma

R. Beart, H. Wieand, L. Rainwater, 1987, Diseases of the colon and rectum.

DNA ploidy in endometrial carcinoma: major objective prognostic factor.

S. Cha, K. Podratz, H. Wieand, 1990, Mayo Clinic proceedings.

Union-Intersection Test for the Mean Vector When the Covariance Matrix is Totally Reducible

H. Wieand, B. K. Sinha, 1979 .

Early stopping of a clinical trial when there is evidence of no treatment benefit: protocol B-14 of the National Surgical Adjuvant Breast and Bowel Project.

B Fisher, J. Bryant, N. Wolmark, 1998, Controlled clinical trials.

Multivariate nonparametric tests for independence

H. Wieand, Bimal K. Sinha, B. K. Sinha, 1977 .

Advanced colorectal adenocarcinoma: treatment with amonafide.

J. Kovach, M. O’connell, J. Rubin, 1994, Journal of the National Cancer Institute.

Quality of life in operable colon cancer patients receiving oral compared with intravenous chemotherapy: results from National Surgical Adjuvant Breast and Bowel Project Trial C-06.

J. Kopec, N. Wolmark, P. Ganz, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

UFT plus calcium folinate vs 5-FU plus calcium folinate in colon cancer.

D. Wickerham, H. Wieand, L. Colangelo, 1999, Oncology.

Randomized phase II trials: what does randomization gain?

H. Wieand, H Samuel Wieand, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The bias of the sample proportion following a group sequential phase II clinical trial.

H. Wieand, M. Chang, H S Wieand, 1989, Statistics in medicine.

UFT/leucovorin vs 5-FU/leucovorin in colon cancer.

B. Lembersky, H. Wieand, L. Colangelo, 2000, Oncology.

Conditional survival for patients with colon cancer: An analysis of National Surgical Adjuvant Breast and Bowel Project (NSABP) trials C-03 through C-06.

N. Wolmark, M. O’connell, J. Dignam, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Patient-reported neurotoxicity with FULV versus FLOX in patients with stage II or III carcinoma of the colon: Results of NSABP Protocol C-07.

J. Kopec, J. Costantino, N. Wolmark, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Syncope in the elderly.

W. Kapoor, H. Wieand, M. Karpf, 1986, The American journal of medicine.

Models of S-phase determination in lymphomas from flow cytometric DNA content histograms: comparison with the bromodeoxyuridine labeling index.

T. Habermann, J. Katzmann, P. Greipp, 1991, Hematologic pathology.

A statistical method for the comparison of a discrete diagnostic test with several continuous diagnostic tests.

C A Beam, C. Beam, H. Wieand, 1991, Biometrics.

A Condition Under Which the Pitman and Bahadur Approaches to Efficiency Coincide

Harry S. Wieand, H. Wieand, 1976 .

Phase II evaluation of menogaril in patients with advanced cervical carcinoma

R. Goldberg, G. Malkasian, J. Laurie, 1991, Investigational New Drugs.

Second Order Efficiency of the MLE with Respect to any Bounded Bowl-Shape Loss Function

J. Ghosh, H. Wieand, B. K. Sinha, 1980 .

Measurement of degraded fecal hemoglobin-heme to estimate gastrointestinal site of occult bleeding appraisal of its clinical utility

D. Ahlquist, H. Wieand, R. Ellefson, 1988, Digestive Diseases and Sciences.

Early Stopping of Cancer Clinical Trials

J. Bryant, J. Dignam, H. Wieand, 2005 .

Optimal designs for a grouped sequential binomial trial

Terry M. Therneau, Harry S. Wieand, Myron Chang, 1990 .